| Literature DB >> 22035856 |
Abstract
Spatial analytical techniques and models are often used in epidemiology to identify spatial anomalies (hotspots) in disease regions. These analytical approaches can be used to identify not only the location of such hotspots, but also their spatial patterns. We used spatial autocorrelation methodologies, including Global Moran's I and Local Getis-Ord statistics, to describe and map spatial clusters and areas in which nine malignant neoplasms are situated in Taiwan. In addition, we used a logistic regression model to test the characteristics of similarity and dissimilarity between males and females and to formulate the common spatial risk. The mean found by local spatial autocorrelation analysis was used to identify spatial cluster patterns. We found a significant relationship between the leading malignant neoplasms and well-documented spatial risk factors. For instance, in Taiwan, the geographic distribution of clusters where oral cavity cancer in males is prevalent was closely correspond to the locations in central Taiwan with serious metal pollution. In females, clusters of oral cavity cancer were closely related with aboriginal townships in eastern Taiwan, where cigarette smoking, alcohol drinking, and betel nut chewing are commonplace. The difference between males and females in the spatial distributions was stark. Furthermore, areas with a high morbidity of gastric cancer were clustered in aboriginal townships where the occurrence of Helicobacter pylori is frequent. Our results revealed a similarity between both males and females in spatial pattern. Cluster mapping clarified the spatial aspects of both internal and external correlations for the nine malignant neoplasms. In addition, using a method of logistic regression also enabled us to find differentiation between gender-specific spatial patterns.Entities:
Mesh:
Year: 2011 PMID: 22035856 PMCID: PMC4013298 DOI: 10.5732/cjc.011.10122
Source DB: PubMed Journal: Chin J Cancer ISSN: 1944-446X
Figure 1.Map of urban areas and aboriginal townships in the study areas.
Map of the study areas was divided into 349 administrative districts, including seven urban areas and an integrated area of 54 plain and aboriginal mountain townships.
Association between Ubc9 expression and clinicopathologic features of breast cancer
| Leading malignant neoplasms (ICD code) | Malea | Femalea | Ratio (male: female) |
| Tracheal, bronchial, and lung cancer (ICD 162) | 145.32 | 94.49 | 1.54 |
| Liver and intrahepatic bile duct cancer (ICD 155) | 241.78 | 122.88 | 1.97 |
| Colon and rectal cancer (ICD 153, 154) | 260.49 | 212.00 | 1.23 |
| Stomach cancer (ICD 151) | 77.96 | 49.68 | 1.57 |
| Oral cavity cancer (ICD 140, 141, 143–146, 148, 149) | 169.83 | 23.24 | 7.31 |
| Esophageal cancer (ICD 150) | 35.42 | 5.35 | 6.62 |
| Pancreatic cancer (ICD 157) | 21.08 | 18.02 | 1.17 |
| Non-Hodgkin's lymphoma (ICD 200, 202, 203) | 56.31 | 45.31 | 1.24 |
| Leukemia (ICD 204–208) | 36.85 | 31.09 | 1.19 |
Data were collected between 2005 and 2009.a indicates age-adjusted prevalence rates per 100 000 people.
Global autocorrelation analysis of data for the nine malignant neoplasms In Taiwan according to gender
| Leading malignant neoplasms (ICD code) | Male | Female | ||
| Moran's index | Z(I) | Moran's index | Z(I) | |
| Tracheal, bronchial, and lung cancer (ICD 162) | 0.51 | 15.95* | 0.21 | 6.55* |
| Liver and intrahepatic bile duct cancer (ICD 155) | 0.56 | 17.60* | 0.40 | 12.77* |
| Colon and rectal cancer (ICD 153, 154) | 0.55 | 17.31* | 0.47 | 15.39* |
| Stomach cancer (ICD 151) | 0.43 | 13.86* | 0.35 | 11.16* |
| Oral cavity cancer (ICD 140, 141, 143–146, 148, 149) | 0.68 | 21.09* | 0.58 | 18.41* |
| Esophageal cancer (ICD 150) | 0.27 | 8.45* | 0.23 | 7.51 * |
| Pancreatic cancer (ICD 157) | 0.22 | 6.92* | 0.23 | 7.31* |
| Non-Hodgkin's lymphoma (ICD 200, 202, 203) | 0.07 | 2.29* | 0.02 | 0.75 |
| Leukemia (ICD 204–208) | 0.05 | 1.74 | 0.10 | 3.55* |
Data were collected between 2005 and 2009. A value In Z(I) greater than 1.96 Is statistically significant and Is Indicated by an asterisk (*).
Figure 2.Spatial clusters (hot spots) of the nine malignant neoplasms in Taiwan.
Maps show the spatial clusters of the nine malignant neoplasms in Taiwan: tracheal, bronchial, and lung cancer are designated by A; liver and intrahepatic bile duct cancer by B; colon and rectal cancer by C; stomach cancer is designated by D; oral cavity cancer by E; and esophageal cancer by F; pancreatic cancer is designated by G; non-Hodgkin's lymphoma by H; and leukemia by I. Gender is indicated by a number, where male is 1 and female is 2.
Logistic regression model comparisons of the nine malignant neoplasms in Taiwan between 2005 and 2009
| Leading malignant neoplasms (ICD code) | Description | |
| Tracheal, bronchial, and lung cancer (ICD 162) | <0.001 | Dissimilaritya |
| Liver and intrahepatic bile duct cancer (ICD 155) | 0.253 | Similaritya |
| Colon and rectal cancer (ICD 153, 154) | 0.027 | Dissimilaritya |
| Stomach cancer (ICD 151) | 0.197 | Similaritya |
| Oral cavity cancer (ICD 140, 141, 143–146, 148, 149) | <0.001 | Dissimilaritya |
| Esophageal cancer (ICD 150) | <0.001 | Dissimilaritya |
| Pancreatic cancer (ICD 157) | 0.217 | Similaritya |
| Non-Hodgkin's lymphoma (ICD 200, 202, 203) | 0.009 | Dissimilarity |
| Leukemia (ICD 204–208) | 0.760 | Similarity |
a indicates that both compared sides must be Moran's tested clusters.